On 2025-05-13, Y-mAbs Therapeutics, Inc. (YMAB) announced earnings per share of $-0.12 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.22.
The next expected annoucement date for quarterly earnings is 2025-08-11, with an average estimated earnings per share of $-0.27 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-0.22 | $-0.12 |
| 2025-03-04 | 2024-12-31 | $-0.13 | $-0.15 |
| 2024-11-08 | 2024-09-30 | $-0.14 | $-0.16 |
| 2024-08-12 | 2024-06-30 | $-0.13 | $-0.21 |
| 2024-05-07 | 2024-03-31 | $-0.12 | $-0.15 |
| 2024-02-29 | 2023-12-31 | $-0.19 | $-0.02 |
| 2023-11-13 | 2023-09-30 | $-0.16 | $-0.18 |
| 2023-08-10 | 2023-06-30 | $-0.24 | $-0.14 |
| 2023-05-08 | 2023-03-31 | $-0.31 | $-0.15 |
| 2023-03-30 | 2022-12-31 | $-0.44 | $0.03 |
| 2022-11-07 | 2022-09-30 | $-0.75 | $-0.63 |
| 2022-08-08 | 2022-06-30 | $-0.68 | $-0.94 |
| 2022-05-09 | 2022-03-31 | $-0.71 | $-0.64 |
| 2022-02-24 | 2021-12-31 | $-0.71 | $-0.85 |
| 2021-11-04 | 2021-09-30 | $-0.60 | $-0.66 |
| 2021-08-05 | 2021-06-30 | $-0.68 | $-0.53 |
| 2021-05-06 | 2021-03-31 | $0.61 | $0.75 |
| 2021-02-25 | 2020-12-31 | $-0.85 | $-0.49 |
| 2020-11-05 | 2020-09-30 | $-0.80 | $-0.82 |
| 2020-08-06 | 2020-06-30 | $-0.69 | $-1.01 |
| 2020-05-07 | 2020-03-31 | $-0.63 | $-0.66 |
| 2020-03-12 | 2019-12-31 | $-0.67 | $-0.60 |
| 2019-11-13 | 2019-09-30 | $-0.54 | $-0.70 |
| 2019-08-14 | 2019-06-30 | $-0.48 | $-0.53 |
| 2019-05-10 | 2019-03-31 | $-0.40 | $-0.47 |
| 2019-03-22 | 2018-12-31 | $-0.38 | $-0.42 |
| 2018-11-13 | 2018-09-30 | $-0.44 | $-0.42 |